alexa Abstract | Poles apart Inimitability of Brain Targeted Drug Delivery system in Middle of NDDS

International Journal of Drug Development and Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Abstract

In spite of an impressive increase in CNS drug discovery, the biggest obstacle remains the effective delivery of these agents across the blood brain barrier, hence the delivery of therapeutic agents to the brain is limited by the presence of the Blood-Brain Barrier (BBB). In the basic science of brain physiology and disease in the past decade, delivery issues have received minimal attention. Current estimates are that 98% of all small molecule drugs minimally cross the BBB, and negligible amounts of large molecule drugs cross the BBB, except leakage in areas of BBB dysfunction. Lipid soluble drugs with a molecular weight under 400-600 daltons are transported to through a blood-brain barrier by lipid mediated transport. This hindrance has slowed the application of pharmacotherapy and immunotherapy in brain diseases. Hence it is important to unite brain targeted drug discovery and CNS drug delivery as early as possible for CNS drug development process. In this report we review the major advances in brain drug targeting research, including approaches to circumvent the BBB for brain delivery by making use of endogenous transport mechanisms or bypassing the BBB altogether. Among all the approaches used for increasing brain delivery of drugs, the most accepted method is the use of the physiological approach. The physiological approach use specific receptors already expressed on the capillary endothelial cells forming the BBB and necessary for the survival of brain cells. This review intends to detail the recent advances in the field of brain-targeting and drug delivery to CNS.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): AWASARKAR VARSHA BAGADE OM RAMTEKE KULDEEP PATEL BINDIYAPATEL RIDDHI

Keywords

Antioxidant activity, PRAC, Oxalis corniculata

 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords